GRPR and pachyonychia congenita: The GRPR antagonist radioligand 67/68Ga/111In/177Lu-NeoBOMB1 has demonstrated favorable diagnostic characteristics in preclinical PC models, with 68Ga-NeoBOMB1 being particularly effective in detecting PC lesions in patients.